Hyunwoo Jeong

1. Rezurock

• Prepared dossier (PEW)
• Developed Key Value Messages
• Conducted budget impact analysis using a monthly inflow model

2. Fitusiran

• Calculated Weighted Average Price (WAP)

3. Budget Impact Analysis

• Assessed financial impact based on the revised International Reference Pricing (IRP) guideline

4. Evaluation Reports & Strategic Analysis

• Summarized DREC Report: Analyzed reimbursement strategies for newly listed drugs over the past year
• Forecasted Multaq pricing by year in response to generic drug listings

1. Dupixent

• Researched and organized reimbursement criteria and pricing in foreign countries
• Prepared the Information Book
• Assisted in Life Cycle Management (LCM) budget impact analysis
• Updated comparative analysis

2. Rezurock

• Participated in the Value Message Workshop (cross-functional)
• Conducted reimbursement drug research related to chronic GvHD (Benlysta, Defitelio)

3. Vaxigriptetra

• Prepared the vaccine pricing application

4. FOLFOX, CapeOx TNT Regimen

• Assisted in dossier refinement and supplementation

5. Evaluation Reports & Monitoring

• Summarized DREC/ODAC evaluation reports
• Article Monitoring: Provided weekly policy and reimbursement issue summaries every Friday morning

• Provided medication dispensing and counseling services for socially disadvantaged groups, including homeless individuals and foreign workers.

• Elevated student engagement by implementing innovative programs and events.
• Strengthened communication between students, faculty, and administration by organizing regular town hall meetings.